Lumibird SA in brief
Lumibird SA is a listed company in the Diagnostics and Research industry, based in France. Its last known market value was $296 M (January 2024); there is no current figure. In the year to December 2025 it had sales of $254 M and a net profit of $16 M, about 6 cents of profit for every dollar of sales. Its shares trade under the symbol LBIRD.PA (EURONEXT).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
Lumibird SA timeline
- 1974
- 🏁· approximateIncorporated as Lumibird
- 2014
- •Legal Entity Identifier issuedLEI 969500MLJC3ZSZP4L019 registered.
Events of Lumibird SA from the GLEIF LEI register. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in France: #239 (Jan 2020) · #232 (Jan 2021) · #203 (Jan 2022) · #204 (Dec 2022) · #202 (Jul 2023) · #213 (Jan 2024)
Key ratios
- P/E ratio
- —
- Price / sales
- —
- Price / book
- —
- Free cash flow yield
- —
- Net margin
- 6.2%
- Operating margin
- 10.6%
- Return on equity
- 6.5%
- Liabilities / assets
- 51.9%
- Revenue growth
- +13.5%
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $254M | +13.5% | $27M | $16M | 6.2% |
| Dec 2024 | $224M | — | $13M | $6M | 2.7% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2025 | $33M | — | — | $0.72 | — |
| Dec 2024 | $37M | — | — | $0.28 | — |
Annual results
- Revenue
- $254 M
- Operating income
- $27 M
- Net income
- $16 M
For year ending December-2025 · source: official annual report (ESEF)
Balance sheet
- Total assets
- $504 M
- Total liabilities
- $262 M
- Total equity
- $242 M
As of December-2025
Mutual funds holding Lumibird SA#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Dimensional International Small Cap ETFDimensional Fund Advisors LP | 17,980 | $1 M | — | <0.01% | +868% | Jul 31, 2026 |
| 🇺🇸 The Continental Small Company SeriesDimensional Fund Advisors LP | 7,539 | $0 M | — | <0.01% | +590% | Jul 31, 2026 |
| 🇺🇸 Dimensional International Core Equity 2 ETFDimensional Fund Advisors LP | 6,920 | $0 M | — | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 International Core Equity 2 PortfolioDimensional Fund Advisors LP | 5,291 | $0 M | — | <0.01% | +269% | Jul 31, 2026 |
| 🇺🇸 Dimensional International Core Equity Market ETFDimensional Fund Advisors LP | 2,454 | $0 M | — | <0.01% | +209% | Jul 31, 2026 |
| 🇺🇸 International Social Core Equity PortfolioDimensional Fund Advisors LP | 2,119 | $0 M | — | <0.01% | +56% | Jul 31, 2026 |
| 🇺🇸 Dimensional VA International Small PortfolioDimensional Fund Advisors LP | 1,152 | $0 M | — | <0.01% | +180% | Jul 31, 2026 |
| 🇺🇸 World ex U.S. Core Equity PortfolioDimensional Fund Advisors LP | 918 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Avantis Responsible International Equity ETFAmerican Century ETF Trust | 864 | $0 M | — | <0.01% | +0.9% | May 31, 2026 |
| 🇺🇸 Avantis International Small Cap Equity ETFAmerican Century ETF Trust | 565 | $0 M | — | <0.01% | −8.9% | May 31, 2026 |
| 🇺🇸 International Sustainability Core 1 PortfolioDimensional Fund Advisors LP | 531 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Dimensional World ex. U.S. Core Equity 2 ETFDimensional Fund Advisors LP | 331 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Dimensional International Vector Equity ETFDimensional Fund Advisors LP | 12 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Dimensional International Sustainability Core 1 ETFDimensional Fund Advisors LP | 12 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 14 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Lumibird SA scorecard#
Passes 4 of the 5 checks that could be worked out. Fiscal year 2025.
Valuationnot known
- –P/E below its peers' medianNo market cap.
- –Price to book below its peers' medianNo market cap.
- –Price to sales below its peers' medianNo market cap.
- –Free cash flow yield above 5%No market cap.
- –Earnings yield above the 10-year Treasury yieldNo market cap.
- –The price assumes slower growth than the last three years'No market cap.
Growth2 of 2
- ✓Revenue grew in the newest year13.5%Revenue up 13.5% in fiscal 2025.
- –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
- –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
- ✓Earnings per share grew in the newest year0.72 vs 0.28Diluted EPS 0.72 in fiscal 2025 against 0.28 the year before (report's currency).
- –Net income higher than five years earlierNet income of five years earlier is not on file.
- –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
Profitability2 of 3
- ✓Profitable in the newest year$16 MNet income $16 M in fiscal 2025.
- –Profitable in each of the last five yearsFive years of net income are not on file.
- ✓Operating margin above its peers' median10.6%10.6% against Diagnostics and Research's median of -2.4% (66 companies).
- ✗Return on equity above 15%7.0%7.0% in fiscal 2025.
- –Return on invested capital above 10%No return on invested capital on file.
- –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
Financial healthnot known
- –Short-term assets cover short-term liabilitiesCurrent assets and liabilities are not on file.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- –Operating income covers interest five timesInterest expense is not on file.
- –Cash from operations positive in each of the last three yearsThree years of operating cash flow are not on file.
- –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
Shareholder returnsnot known
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- –Share count up no more than 2% in a yearShare counts of two years are not on file.
- –Dividends and buybacks above 3% of the market valueNo market cap.
- –Free cash flow covers dividends and buybacksCash from operations or capital spending is not on file.
Worked out from the statements as filed (esef), the medians of Diagnostics and Research, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2025#
Worked out from Lumibird SA's statements, beside the median of Diagnostics and Research.
| Ratio | Trend | 2025 | Median of peers |
|---|---|---|---|
| Operating margin | 10.6% | -2.4% | |
| Net margin | 6.2% | -3.6% | |
| Return on equity | 7.1% | -5.4% | |
| Revenue growth | 13.5% | 6.6% |
5of 5on the Piotroski tests of financial strength
Lumibird SA: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in EUR millions; per-share figures in EUR; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Dec 31, 2025 | FY 2024to Dec 31, 2024 | FY 2023to Dec 31, 2023 | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 | FY 2020to Dec 31, 2020 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 226+8.9%100% | 207+1.7%100% | 204+6.6%100% | 191+17.5%100% | 162+28.2%100% | 127—100% | |
| Operating income | 24+106%10.6% | 12−5.0%5.6% | 12−29.5%6.0% | 17−9.8%9.0% | 19+121%11.8% | 8.7—6.8% | |
| Interest expense and finance costs | 5.7−8.7%2.5% | 6.3+49.5%3.0% | 4.2+25.2%2.1% | 3.3—1.8% | — | — | |
| Income tax | 4.9+493%2.2% | 0.8+155%0.4% | 0.3−89.4%0.2% | 3.1−17.7%1.6% | 3.7+141%2.3% | 1.6—1.2% | |
| Net income including minority interests | 14+146%6.2% | 5.7−20.1%2.7% | 7.1−37.2%3.5% | 11−18.1%5.9% | 14+146%8.5% | 5.6—4.4% | |
| Minority interests' share of net income | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | |
| Net income attributable to shareholders | 14+146%6.2% | 5.7−20.1%2.7% | 7.1−37.2%3.5% | 11−18.1%5.9% | 14+146%8.5% | 5.6—4.4% | |
| Earnings per share, basic | 0.64+146%— | 0.26−18.8%— | 0.32−37.3%— | 0.51−17.7%— | 0.62+107%— | 0.30—— | |
| Earnings per share, diluted | 0.64+146%— | 0.26−18.8%— | 0.32−37.3%— | 0.51−17.7%— | 0.62+107%— | 0.30—— | |
| Balance sheet | |||||||
| Cash and cash equivalents | 62−13.4%14.4% | 71+26.6%16.6% | 56−8.9%13.9% | 62−36.5%16.6% | 97+20.9%27.9% | 80—26.3% | |
| Inventory | 82+8.0%19.2% | 76−1.5%17.8% | 78+18.6%19.1% | 65+42.7%17.6% | 46+23.2%13.2% | 37—12.2% | |
| Current assets | 217+3.9%50.6% | 209+5.8%48.6% | 197+5.4%48.7% | 187+2.3%50.3% | 183+12.7%52.6% | 162—53.1% | |
| Property, plant and equipment | 45−3.2%10.5% | 47−3.3%10.8% | 48+21.2%11.9% | 40+40.9%10.7% | 28+13.8%8.1% | 25—8.1% | |
| Goodwill | 71−1.9%16.5% | 72−0.7%16.8% | 73+3.8%17.9% | 70−0.5%18.8% | 70+1.5%20.2% | 69—22.7% | |
| Other intangible assets | — | — | — | — | 47+18.4%13.6% | 40—13.1% | |
| Non-current assets | 212−4.1%49.4% | 221+6.3%51.4% | 208+12.5%51.3% | 185+12.2%49.7% | 165+15.1%47.4% | 143—46.9% | |
| Total assets | 429−0.2%100% | 430+6.1%100% | 405+8.9%100% | 372+7.0%100% | 348+13.8%100% | 305—100% | |
| Debt due within a year | — | — | — | — | 14−15.6%4.1% | 17—5.5% | |
| Current liabilities | 88+10.4%20.5% | 79+7.3%18.5% | 74−38.2%18.3% | 120+107%32.2% | 58+1.0%16.7% | 57—18.8% | |
| Long-term debt | — | — | — | — | 98+36.8%28.2% | 72—23.4% | |
| Non-current liabilities | 135−11.5%31.4% | 152+10.5%35.4% | 138+135%34.0% | 59−45.8%15.8% | 108+29.0%31.2% | 84—27.5% | |
| Shareholders' equity | 206+4.2%48.1% | 198+2.4%46.1% | 193−0.1%47.7% | 193+6.7%52.0% | 181+10.5%52.2% | 164—53.7% | |
| Minority interests | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | |
| Total equity | 206+4.2%48.1% | 198+2.4%46.1% | 193−0.1%47.7% | 193+6.7%52.0% | 181+10.5%52.2% | 164—53.7% | |
| Total liabilities and equity | 429−0.2%100% | 430+6.1%100% | 405+8.9%100% | 372+7.0%100% | 348+13.8%100% | 305—100% | |
| Cash-flow statement | |||||||
| Depreciation and amortization | 20+7.8%8.7% | 18+16.4%8.8% | 16+9.5%7.7% | 14+18.9%7.5% | 12+28.3%7.4% | 9.4—7.4% | |
| Cash from operating activities | 29−15.6%12.9% | 34+66.3%16.6% | 21+1348%10.2% | 1.4−94.6%0.7% | 27+103%16.4% | 13—10.4% | |
| Cash from investing activities | −16—−7.1% | −23—−11.0% | −46—−22.7% | −29—−15.4% | −29—−17.6% | −67—−53.0% | |
| Debt issued | 12−85.2%5.3% | 81+60.5%39.3% | 51+233%24.9% | 15−60.3%8.0% | 38−32.9%23.6% | 57—45.0% | |
| Debt repaid | −29—−12.7% | −72—−34.7% | −22—−10.8% | −19—−9.8% | −18—−11.1% | −3.9—−3.1% | |
| Shares issued | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | — | — | |
| Dividends paid | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | — | — | |
| Cash from financing activities | −22−753%−9.8% | 3.4−84.4%1.6% | 22—10.7% | −7.9−143%−4.1% | 18−78.5%11.2% | 85—66.9% | |
| Exchange-rate effect on cash | −0.5−763%−0.2% | 0.1—0.0% | −0.4−316%−0.2% | 0.2−73.0%0.1% | 0.6—0.4% | −0.6—−0.5% | |
| Change in cash | −9.6−164%−4.3% | 15—7.2% | −4.2—−2.0% | −36−312%−18.7% | 17−44.3%10.3% | 30—23.8% | |
| Report | ESEF | ESEF | ESEF | ESEF | ESEF | ESEF | |
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: ESEF annual reports (filings.xbrl.org) · as of Dec 31, 2025. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
How Lumibird SA compares in Diagnostics and Research
- Revenue$254 M · higher than 46% of 123
- Net margin6.2% · higher than 53% of 112
- Revenue growth13.5% · higher than 67% of 89
Peer comparison · Diagnostics and Research
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Lumibird SA🇫🇷 | $296 M | — | 6.2% | +13.5% |
| Thermo Fisher Scientific Inc.🇺🇸 | $253.8 B | 35.9× | 14.9% | +3.9% |
| Danaher Corporation🇺🇸 | $166.7 B | 38.5× | 16.9% | +2.9% |
| WuXi AppTec Co., Ltd.🇨🇳 | $70.4 B | 25.4× | 42.1% | — |
| Natera, Inc.🇺🇸 | $58.7 B | — | -5.7% | +35.9% |
| Siemens Healthineers AG🇩🇪 | $52.8 B | 22.9× | 8.7% | — |
| Lonza Group AG🇨🇭 | $51.9 B | — | -4.2% | — |
| Agilent Technologies, Inc.🇺🇸 | $48.8 B | 33.9× | 19.5% | +6.7% |
| IQVIA Holdings Inc.🇺🇸 | $45.1 B | 32.4× | 8.1% | +5.9% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Thermo Fisher Scientific Inc.$253.8 B
- Danaher Corporation$166.7 B
- WuXi AppTec Co., Ltd.$70.4 B
- Natera, Inc.$58.7 B
- Siemens Healthineers AG$52.8 B
- Lonza Group AG$51.9 B
Sources and freshness
- Market cap:
- Jan 5, 2024 (last known)
- Annual results:
- For year ending December-2025
- Balance sheet:
- As of December-2025
- Profile updated:
- Nov 15, 2026
Figures from Official annual report (ESEF), value.today research, GLEIF register.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Lumibird SA? Verify and update this profile — free
Show Lumibird SA's ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.